MetaCap

PROCEPT BioRobotics (PRCT) vs DENTSPLY SIRONA (XRAY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

PROCEPT BioRobotics (PRCT) has outperformed DENTSPLY SIRONA (XRAY) over the past year, losing 17.3% versus a loss of 21.6%. Over five years, PRCT leads with a -30.6% price change compared with -83.4% for XRAY. DENTSPLY SIRONA is the larger company by market cap ($1.65 billion vs $1.42 billion), about 1.2 times the size, while PROCEPT BioRobotics is growing revenue faster (+37.2% vs -3.0%).

DENTSPLY SIRONA pays a dividend yielding 1.93%, while PROCEPT BioRobotics does not currently pay one. DENTSPLY SIRONA converts more of its revenue into profit, with a net margin of -16.3% versus -31.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PRCT-17.28%XRAY-21.64%
+43%-3%-48%
Nov 21, 20251 yearNov 20, 2026
PRCT-39.28%XRAY-84.27%
+155%+30%-96%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PRCT versus XRAY key metrics
MetricPRCTXRAY
Share price$24.70$8.29
Market cap$1.42B$1.65B
1-day change-4.08%-2.36%
YTD return-21.49%-27.47%
1-year return-17.28%-21.64%
5-year return-30.64%-83.35%
Forward P/E—6.78
EPS (TTM)$-2.02$-0.61
Dividend yield0.00%1.93%
Annual dividend$0.00$0.16
Revenue (latest FY)$308.05M$3.68B
Revenue growth (YoY)+37.22%-2.98%
Net income (latest FY)$-95.57M$-598.00M
Gross margin63.70%50.00%
Operating margin-33.71%-11.47%
Net margin-31.02%-16.25%
52-week high$38.11$14.76
52-week low$16.67$8.14
Distance from 52-week high-35.19%-43.83%
Analyst consensusholdhold
Avg. price target upside-7.89%+29.92%
Average volume1.31M4.81M
Shares outstanding57.54M199.35M
Employees88814,000
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • DENTSPLY SIRONA offers a meaningfully higher dividend yield (1.93% vs 0.00%).
  • DENTSPLY SIRONA is more profitable, keeping -16.3 cents of every revenue dollar as net income versus -31.0 cents for PROCEPT BioRobotics.
  • PROCEPT BioRobotics grew revenue faster in its latest fiscal year (+37.22% vs -2.98%).

About PROCEPT BioRobotics

PRCT stock →

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia.

Health Care · Medical/Dental Instruments · 888 employees

About DENTSPLY SIRONA

XRAY stock →

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.

Health Care · Medical/Dental Instruments · 14,000 employees

PRCT vs XRAY FAQ

Which is bigger, PROCEPT BioRobotics or DENTSPLY SIRONA?

DENTSPLY SIRONA (XRAY) is larger, with a market capitalization of $1.65B compared with $1.42B for PROCEPT BioRobotics (PRCT).

Which stock has performed better over the past year, PRCT or XRAY?

PRCT returned -17.28% over the past 12 months, compared with -21.64% for XRAY (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, PROCEPT BioRobotics or DENTSPLY SIRONA?

DENTSPLY SIRONA pays a dividend yielding 1.93%, while PROCEPT BioRobotics does not currently pay a regular dividend.

Are PROCEPT BioRobotics and DENTSPLY SIRONA in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons